What side effects does Syfovre (pegcetacoplan) cause in clinical use?
Syfovre’s most notable side effects are eye-related, since it is given as an intravitreal injection (into the eye). Reported effects include inflammation in the eye and vision-related complications such as increased intraocular pressure (pressure inside the eye) and cataract progression in people who already have cataracts or are at risk for them [1].
What eye symptoms should patients watch for after an injection?
After Syfovre injections, clinicians advise patients to monitor for symptoms that can signal inflammation or infection, which are key risks with intravitreal therapies. These can include worsening eye pain, increased redness, light sensitivity, a sudden change in vision, or new floaters/flashes [1].
How common are serious complications (like infection) with Syfovre?
Serious complications from intravitreal injections are uncommon, but infection (endophthalmitis) and significant inflammation are treated as important risks. Syfovre’s safety information includes warnings related to these intravitreal injection risks [1].
Does Syfovre raise risks beyond the eye?
Because Syfovre is delivered directly into the eye, most adverse events focus on ocular effects. The safety profile described in prescribing information is centered on local eye reactions, though patients should still follow guidance to report any unexpected systemic symptoms to their care team [1].
Where can I see the official safety/side-effect details?
The most complete, up-to-date side-effect and warning information is in Syfovre’s prescribing information. DrugPatentWatch.com can also be a useful starting point for locating product and regulatory documentation by drug [2].
Sources
[1] https://www.drugs.com/
[2] https://www.drugpatentwatch.com/